Articles

  • Oct 14, 2024 | gmu.edu | Laura Powers

    Researchers in the College of Science at George Mason University recently secured a $1.4M grant from the Defense Threat Reduction Agency (DTRA) to investigate how an infection spreads between organs, and how a therapeutic will impact connected organs. The work will initially focus on mosquito- transmitted viruses while scientists also hope to expand the implications from these studies to other human disease states.

  • Aug 20, 2024 | gmu.edu | Laura Powers

    Fereshte Ghahari Kermani, assistant professor in physics and astronomy in George Mason University’s College of Science, received the prestigious Early Career Development (CAREER) Program grant from the National Science Foundation (NSF) to continue her research on the complex quantum phases in graphene materials.

  • Aug 14, 2024 | gmu.edu | Laura Powers

    George Mason University’s popular FOCUS outreach program marks its 10th anniversary this summer and continues to expand its science and tech immersion programs.

  • Aug 12, 2024 | medicalxpress.com | Laura Powers |George Mason

    Scientists have long studied the spread of diseases, but the emergence of COVID-19 and its profound impact on society have underscored the critical need to understand where and how diseases spread. As George Mason University doctoral student Jericho McLeod reviewed literature on disease transmission as part of his work toward a Ph.D. in computational science and informatics, he and George Mason professor Eduardo López noticed a gap in the models and now seek to correct it.

  • Jul 25, 2024 | gmu.edu | Laura Powers

    Researchers in George Mason University’s Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center conducted a breakthrough proof-of-concept study, published in Nature’s Gene Therapy, that found a human immunodeficiency virus (HIV)-like virus particle that could cease the need for lifelong medications.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →